[1]
Tamzaourte, M. et al. 2021. Safety and efficacy of sofosbuvir based regimen in the treatment of hepatitis C virus infection among hemodialysis patients in Morocco. Journal of Clinical Nephrology. 5, 3 (Aug. 2021), 077–080. DOI:https://doi.org/10.29328/journal.jcn.1001078.